title: The US Food and Drug Administration's registry of patients with pergolide-associated valvular heart disease.
authors.affiliation: Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD, USA. flowersc@cder.fda.gov
authors.forename: Charlene M
authors.initials: CM
authors.lastname: Flowers
authors.forename: Judith A
authors.initials: JA
authors.lastname: Racoosin
authors.forename: Susan L
authors.initials: SL
authors.lastname: Lu
authors.forename: Julie G
authors.initials: JG
authors.lastname: Beitz
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D001530:Belgium; D003718:Denmark; D018491:Dopamine Agonists / Q000009:adverse effects*; D005387:Finland; D006349:Heart Valve Diseases / Q000139:chemically induced* / Q000473:pathology*; D006801:Humans; D010479:Pergolide / Q000009:adverse effects*; D012042:Registries; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D018491:Dopamine Agonists; D010479:Pergolide